Trial Profile
A Phase II Study Of Intravenous T900607-Sodium In Subjects With Previously Treated Gastric Carcinoma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 Jul 2013
Price :
$35
*
At a glance
- Drugs T 900607 (Primary)
- Indications Gastric cancer
- Focus Therapeutic Use
- 29 Sep 2005 New trial record.